4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

4 - Hinge Health, Inc. (0001673743) (Issuer)

144 - Hinge Health, Inc. (0001673743) (Subject)

144 - Hinge Health, Inc. (0001673743) (Subject)

144 - Hinge Health, Inc. (0001673743) (Subject)

10-Q - Hinge Health, Inc. (0001673743) (Filer)

144 - Hinge Health, Inc. (0001673743) (Subject)

8-K - Hinge Health, Inc. (0001673743) (Filer)

SCHEDULE 13G - Hinge Health, Inc. (0001673743) (Subject)

DEFA14A - Hinge Health, Inc. (0001673743) (Filer)

DEF 14A - Hinge Health, Inc. (0001673743) (Filer)

SCHEDULE 13G/A - Hinge Health, Inc. (0001673743) (Subject)

Wells Fargo initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $68.00

Robert W. Baird initiated coverage of Hinge Health with a rating of Neutral and set a new price target of $56.00

Citizens JMP initiated coverage of Hinge Health with a rating of Mkt Outperform and set a new price target of $58.00

William Blair initiated coverage of Hinge Health with a rating of Outperform

Truist initiated coverage of Hinge Health with a rating of Buy and set a new price target of $48.00

Stifel initiated coverage of Hinge Health with a rating of Buy and set a new price target of $48.00

Raymond James initiated coverage of Hinge Health with a rating of Outperform and set a new price target of $45.00

Piper Sandler initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $41.00

Morgan Stanley initiated coverage of Hinge Health with a rating of Overweight and set a new price target of $46.00

Needham initiated coverage of Hinge Health with a rating of Buy and set a new price target of $47.00

The study analyzed over 200,000 participants from nearly 1,000 employers over five years, finding $2,941 savings per member annually Hinge Health, Inc. (NYSE:HNGE) today announced the results of the most comprehensive medical claims analysis of its digital musculoskeletal (MSK) solution, demonstrating an average cost savings of $2,941 per member per year using its chronic MSK program and a 3.0x ROI for employers and health plans. With a rigorous methodology independently reviewed by Howden, a global leading benefits consultant, the study dwarfs all prior ROI studies in digital MSK. It analyzed claims data for more than 200,000 commercially-insured adults ages 18-64 across nearly 1,000 e

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, May 28, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on May 28thTraders are reacting to new developments out of the Middle East following a report that the U.S. carried out strikes on an Iranian military site near the Strait of Hormuz.Shares of Global X NYSE 100 ETF component Snowflake (NYSE:SNOW) are spiking ahead of the open after Q1 earnings and announcing a $6 billion deal wit

Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the first quarter ended March 31, 2026. "We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs," said Daniel Perez, Co-Founder and CEO, Hinge Health. "Based on this momentum, we're raising our full-year revenue outlook by approximately $64 million at the midpoint to $801 million, while expanding non-GAAP operating margin to 26%. We also recently announced our Migraine Care Program, an important step in expanding our platform. We didn't build this company to s

Cleared by the FDA for migraine, Hinge Health's Enso® delivers on-demand pain relief Already 125+ clients covering more than two million people have adopted the Migraine Care Program Hinge Health, Inc. (NYSE:HNGE) today introduced its Migraine Care Program, offering rapid drug-free pain relief, personalized trigger management, and expert-led prevention for members. With meaningful overlap between the treatments and clinical best practices for migraine and musculoskeletal (MSK) care, Hinge Health is leveraging its proven expertise in nerve stimulation, exercise therapy, and behavior change to deliver comprehensive, whole-person care for people living with migraine, MSK pain, or both.

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting wit

Hinge Health, Inc. (NYSE:HNGE) today announced its expansion throughout the public sector, now delivering musculoskeletal (MSK) care to employees across 24 state employee health plan clients. With MSK conditions continuing to be a top healthcare cost driver, leading state governments are taking a different approach, prioritizing early intervention, accessibility, and evidence-based care that meets employees where they are. "Providing our team with a digital program that fits into their busy lives ensures they get the right care at the right time," said Karyn Williams, Program Manager at Employees' Group Insurance for the State of Wyoming. "By adding Hinge Health as a benefit for our emplo

Hinge Health, Inc. (NYSE:HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement. "Tyler brings decades of deep operating experience," said Daniel Perez, Co-Founder and CEO, Hinge Health. "His track record of scaling public companies with operational rigor and financial discipline will be instrumental as we advance our mission to automate healthcare delivery." As a seasoned executive and board member, Sloat has nearly three decades of operational leadership guid

Hinge Health, Inc. (NYSE:HNGE) today announced record financial results for the quarter and year ended December 31, 2025. "We closed out the year with an exceptional quarter and a strong selling season, driving our highest win rates to date and greatest number of eligible lives added in any year," said Daniel Perez, Co-Founder and CEO, Hinge Health. "Our commercial momentum, combined with expanding margins and strong cash generation, gives us confidence in our ability to continue automating care delivery, sustain our position as a leader in digital musculoskeletal care, and drive attractive growth and increased margins in 2026." Fourth Quarter 2025 Financial Highlights: Revenue incre

Today, Hinge Health (NYSE:HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today's fragmented healthcare system leaves many people unsure how to pursue treatment for MSK pain. Hinge Health surveyed 1,000 people living with MSK pain alongside 295 healthcare providers to understand the systemic challenges and opportunities for industry-wide improvements. The dual-perspective survey – along with real patient and provider stories – maps a clear path to more effective, unified care. "While Hinge Health's digital physical therapy program has dramatically increased access, MSK care still feels like a maze for too many people," said Dr. Jeffrey Krauss, MD,

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the fourth quarter and full year 2025 after the U.S. financial markets close on Tuesday, February 10, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, st

Hinge Health, Inc. (NYSE:HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement. "Tyler brings decades of deep operating experience," said Daniel Perez, Co-Founder and CEO, Hinge Health. "His track record of scaling public companies with operational rigor and financial discipline will be instrumental as we advance our mission to automate healthcare delivery." As a seasoned executive and board member, Sloat has nearly three decades of operational leadership guid

Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the first quarter ended March 31, 2026. "We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs," said Daniel Perez, Co-Founder and CEO, Hinge Health. "Based on this momentum, we're raising our full-year revenue outlook by approximately $64 million at the midpoint to $801 million, while expanding non-GAAP operating margin to 26%. We also recently announced our Migraine Care Program, an important step in expanding our platform. We didn't build this company to s

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended March 31, 2026, after the U.S. financial markets close on Tuesday, May 5, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting wit

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the fourth quarter and full year 2025 after the U.S. financial markets close on Tuesday, February 10, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, st

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarter ended September 30, 2025, after the U.S. markets close on Tuesday, November 4, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting with

Hinge Health, Inc. (NYSE:HNGE) today announced financial results for the second quarter ended June 30, 2025. "In Q2 we delivered year-over-year revenue growth of 55% and a strong free cash flow margin, underlining the market's embrace of our AI-powered platform," said Daniel Perez, Co-Founder and CEO, Hinge Health. "The journey of automating healthcare delivery will be challenging, but we're excited about our momentum and are moving with haste to capture this opportunity." Second Quarter 2025 Financial Highlights: Revenue increased 55% year-over-year to $139.1 million compared to revenue of $89.8 million in Q2 2024. GAAP gross margin was 70% compared to 74% in Q2 2024. Non-GAAP gr

Hinge Health, Inc. (NYSE:HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at ir.hingehealth.com. A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting w